Pioglitazone improves deficits of Fmr1-KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signaling
Andréa Geoffroy, Karima Habbas, Boglárka Zámbó, Laetitia Schramm, Arnaud Duchon, Eric Flatter, Laëtitia Fouillen, Julie Zumsteg, Dimitri Heintz, Jean‐Louis Mandel, Yann Hérault, Hervé Moine
This study shows pioglitazone reduces excessive diacylglycerol signaling in Fmr1-KO mice, improving behavioral deficits associated with Fragile X syndrome.
bioRxiv · Sep 22, 2020 · PreprintNeuroscience